Intraprostatic distribution and long-term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer-Reference-Cited by-同舟云学术

Intraprostatic distribution and long-term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer

Published:2013-09-20 Issue:11 Volume:20 Page:642-649
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Rojas-Martínez A,Manzanera A G,Sukin S W,Esteban-María J,González-Guerrero J F,Gomez-Guerra L,Garza-Guajardo R,Flores-Gutiérrez J P,Elizondo Riojas G,Delgado-Enciso I,Ortiz-López R,Aguilar L K,Butler E B,Barrera-Saldaña H A,Aguilar-Cordova E

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/cgt201356.pdf

Reference31 articles.

1. Jemal A, Siegel R, Xu J, Ward E . Cancer statistics. CA Cancer J Clin 2010; 60: 277–300.

2. Ferlay J Cancer Incidence and Mortality Worldwide. GLOBOCAN 2008 v2.0 (2010).at < http://globocan.iarc.fr >.

3. Gomez-Guerra LS, Martinez-Fierro ML, Alcantara-Aragon V, Ortiz-Lopez R, Martinez-Villarreal RT, Morales-Rodriguez IB et al. Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases. BMC Cancer 2009; 9: 91.

4. Walsh PC, DeWeese TL, Eisenberger MA . Clinical practice. Localized prostate cancer. N Engl J Med 2007; 357: 2696–2705.

5. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 1591–1597.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomoléculas para la programación y el entrenamiento celular;Revista Ciencia UANL;2023-11-09

2. Clinical Efficacy and Safety of AdV-tk Gene Therapy for Patients with Cervical Squamous Intraepithelial Lesion: A Prospective Study;Human Gene Therapy;2023-10-01

3. Anticancer Activity of Measles–Mumps–Rubella MMR Vaccine Viruses against Glioblastoma;Cancers;2023-08-28

4. Intratumoral delivery of immune therapy and gene therapy: the next era for cancer therapy;Immunotherapy;2023-08

5. Development and application of oncolytic viruses as the nemesis of tumor cells;Frontiers in Microbiology;2023-06-12